Joseph Macaluso
Nessuna posizione attualmente
Profilo
Joseph P.
Macaluso served as the Chief Financial & Accounting Officer at Electro Catheter Corp.
from 2010 to 2011.
He also held the same position at Tel-Instrument Electronics Corp.
from 2010 to 2012.
Currently, he is the Chief Financial Officer at QXO, Inc. from 2021 to 2024.
Mr. Macaluso completed his undergraduate degree at Fairfield University.
Precedenti posizioni note di Joseph Macaluso
Società | Posizione | Fine |
---|---|---|
QXO, INC. | Direttore Finanziario/CFO | 06/06/2024 |
TEL-INSTRUMENT ELECTRONICS CORP. | Direttore Finanziario/CFO | 07/02/2012 |
Electro Catheter Corp.
Electro Catheter Corp. Medical SpecialtiesHealth Technology Electro-Catheter Corp. designs, develops, manufactures and markets products utilized in connection with illnesses of the heart and circulatory system and make use of catheters and related products. The company has targeted electrophysiology as its focal area for future growth, but intends to maintain and develop products for the emergency care, invasive and non-invasive cardiology and invasive radiology markets. The company also continues to explore opportunities to expand its Original Equipment Manufacturing business and contract research and development business to capitalize on its catheter technology expertise and its manufacturing capabilities. The Company was founded in 1961 and is headquartered in Rahway, NJ. | Direttore Finanziario/CFO | 10/01/2011 |
Formazione di Joseph Macaluso
Fairfield University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
TEL-INSTRUMENT ELECTRONICS CORP. | Electronic Technology |
QXO, INC. | Commercial Services |
Aziende private | 1 |
---|---|
Electro Catheter Corp.
Electro Catheter Corp. Medical SpecialtiesHealth Technology Electro-Catheter Corp. designs, develops, manufactures and markets products utilized in connection with illnesses of the heart and circulatory system and make use of catheters and related products. The company has targeted electrophysiology as its focal area for future growth, but intends to maintain and develop products for the emergency care, invasive and non-invasive cardiology and invasive radiology markets. The company also continues to explore opportunities to expand its Original Equipment Manufacturing business and contract research and development business to capitalize on its catheter technology expertise and its manufacturing capabilities. The Company was founded in 1961 and is headquartered in Rahway, NJ. | Health Technology |
- Borsa valori
- Insiders
- Joseph Macaluso